Page last updated: 2024-09-03
l 158809 and halothane
l 158809 has been researched along with halothane in 1 studies
Compound Research Comparison
| Studies (l 158809) | Trials (l 158809) | Recent Studies (post-2010) (l 158809) | Studies (halothane) | Trials (halothane) | Recent Studies (post-2010) (halothane) |
|---|---|---|---|---|---|
| 137 | 0 | 7 | 14,369 | 884 | 235 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hashimoto, K; Satoh, Y; Sugiyama, A; Yoneyama, M; Yoshida, H | 1 |
Other Studies
1 other study(ies) available for l 158809 and halothane
| Article | Year |
|---|---|
Cardiovascular effects of L-158,809, a new angiotensin type 1 receptor antagonist, assessed using the halothane-anesthetized in vivo canine model.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiovascular System; Dogs; Dose-Response Relationship, Drug; Halothane; Imidazoles; Models, Animal; Receptors, Angiotensin; Tetrazoles | 2002 |